Should Modest Elevations in Prostate-Specific Antigen, International Prostate Symptom Score, or Their Rates of Increase Over Time be Used as Surrogate Measures of Incident Benign Prostatic Hyperplasia?

類似資料

• Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial
  著者:: Schenk, Jeannette M., 等
  出版事項: (2011)
• Indications For and Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
  著者:: Schenk, Jeannette M., 等
  出版事項: (2012)
• Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
  著者:: Schenk, Jeannette M., 等
  出版事項: (2010)
• Serum Adiponectin, C-peptide and Leptin and Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
  著者:: Schenk, Jeannette M., 等
  出版事項: (2009)
• Finasteride Reduces the Risk of Incident Clinical Benign Prostatic Hyperplasia
  著者:: Parsons, J. Kellogg, 等
  出版事項: (2012)